Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. [electronic resource]
- Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons Apr 2012
- 821-9 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1531-5053
10.1016/j.joms.2011.02.093 doi
Administration, Oral Aged Alcoholism--epidemiology Alendronate--administration & dosage Bisphosphonate-Associated Osteonecrosis of the Jaw--epidemiology Bone Density Conservation Agents--administration & dosage Case-Control Studies Cohort Studies Denmark--epidemiology Diabetes Complications--epidemiology Diphosphonates--administration & dosage Drug Therapy--statistics & numerical data Etidronic Acid--administration & dosage Female Humans Jaw Diseases--epidemiology Male Neoplasms--epidemiology Organometallic Compounds--administration & dosage Osteitis--epidemiology Osteomyelitis--epidemiology Osteoporosis--drug therapy Parathyroid Hormone--administration & dosage Periostitis--epidemiology Radiotherapy--statistics & numerical data Raloxifene Hydrochloride--administration & dosage Risk Factors Sjogren's Syndrome--epidemiology Strontium--administration & dosage Thiophenes--administration & dosage